Delhi Journal of Ophthalmology

Biologics in Oculoplasty

Priyanka Golhait, Gaurav Singh
Department of Ophthalmology, Guru Nanak Eye Centre, New Delhi, India

Editor-in-Chief, Delhi Journal of Ophthalmology, Dr R.P.Centre, AIIMS.

Corresponding Author:

Priyanka Golhait (MBBS, MS, DNB)
Department of Ophthalmology, 
Guru Nanak Eye Centre, New Delhi, India

Received: 10-MAR-2022 Accepted: 05-APR-2022 Published Online: 03-APR-2022

Recent advancements in oncology and immunology have led to the development of biologics, which are newer drugs that target specific molecules involved in tumorigenesis and inflammatory pathways. The current use of targeted therapy has transformed the therapeutic approach for many orbital cancers and inflammatory disorders that were previously treated with conventional treatment modalities. The purpose of this article is to highlight the therapeutic potential of targeted therapy for common orbital cancers and inflammatory conditions.

Keywords :Biologics Targeted Therapy Monoclonal Antibodies Small Molecule Inhibitors Hedgehog Pathway

Search PubMed for

Search Google Scholar for

Article Statistics